Senior Scientific Advisor
Dr Högberg has spent over 40 years in the pharmaceutical industry and had leading roles from early drug discovery up to marketed products. He has experience from big pharma (Astra and AstraZeneca), mid pharma (ALK-Abelló), biotech (7TM Pharma) and presently LEO Pharma. He led medicinal chemistry organizations and drug development in several therapeutic areas including dermatology, pain, obesity, diabetes, dyslipidaemia, inflammatory diseases, respiratory diseases, depression, psychosis, and infection. He is a Fellow of the Royal Society of Chemistry (CChem, FRSC), Assoc. Prof. at the Royal Institute of Technology, Stockholm and he has published over 100 scientific papers and 50 patent applications.
Drug discovery, medicinal chemistry